ERAS

NASDAQStock$9.22-0.68 (-6.82%)
Mkt Cap 2.9BP/E Div Yield Beta 1.05Vol 5.0M
52W$1.08
$22.47

ETFs That Hold ERAS (Erasca, Inc.)

1M

-38.25%

3M

-10.52%

6M

+281.20%

YTD

+156.96%

1Y

+545.10%

3Y

+227.13%

5Y

-47.07%

ETFs That Hold ERAS

Erasca, Inc. is held by 68 ETFs. The largest position by market value is in IWM (iShares Russell 2000 ETF).

ETFFund NameWeight
IWMiShares Russell 2000 ETF0.13%
XBIState Street SPDR S&P Biotech ETF1.09%
VTIVanguard Total Stock Market ETF0.00%
IWNiShares Russell 2000 Value ETF0.27%
IBBiShares Biotechnology ETF0.38%
VXFVanguard Extended Market ETF0.03%
SCHASchwab U.S. Small-Cap ETF0.12%
TCAFT. Rowe Price Capital Appreciation Equity ETF0.18%
FESMFidelity Enhanced Small Cap ETF0.21%
DFACDimensional - US Core Equity 2 ETF0.02%
VTWOVanguard Russell 2000 ETF0.06%
VHTVanguard Health Care ETF0.04%
AVSCAvantis U.S. Small Cap Equity ETF0.28%
IWCiShares Micro-Cap ETF0.56%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
DWASInvesco Dorsey Wright SmallCap Momentum ETF1.56%
DFASDimensional - US Small Cap ETF0.04%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.14%
PTHInvesco Dorsey Wright Healthcare Momentum ETF3.45%
CANCTema Oncology ETF2.37%

Excludes leveraged and inverse ETFs.

Page 1 of 4Next

Frequently Asked Questions

How many ETFs hold ERAS?
Erasca, Inc. (ERAS) is held by 68 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IWM (iShares Russell 2000 ETF).
What is the largest ETF that holds ERAS?
By fund size, IWM (iShares Russell 2000 ETF) with $75.96B in AUM holds 0.13% of its portfolio in ERAS, representing $98.5M in market value.
What percentage of BBC is ERAS?
ERAS makes up 3.56% of BBC (Virtus Biotech Clinical Trials ETF), making it one of the largest positions in that fund.
Is ERAS in the S&P 500?
ERAS is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.